Evista and Haemorrhoids aggravated - a phase IV clinical study of FDA data

Summary:

Haemorrhoids aggravated is reported as a side effect among people who take Evista (raloxifene hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Fosamax, and have Breast cancer.

The phase IV clinical study analyzes which people have Haemorrhoids aggravated when taking Evista. It is created by eHealthMe based on reports of 25,442 people who have side effects when taking Evista from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Haemorrhoids aggravated?

Haemorrhoids aggravated (a serious swollen vein or group of veins in the region of the anus) is found to be associated with 1,316 drugs and 453 conditions by eHealthMe. Check the latest studies of Haemorrhoids aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

25,442 people reported to have side effects when taking Evista.
Among them, 147 people (0.58%) have Haemorrhoids aggravated.

Could Evista cause Haemorrhoids aggravated?

Among these 147 people:

How long have people been on Evista when they have Haemorrhoids aggravated? *

Click here to view more results

What is the gender of people who have Haemorrhoids aggravated when taking Evista? *

Click here to view

What is the age of people who have Haemorrhoids aggravated when taking Evista? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Evista and have Haemorrhoids aggravated?

- Check whether Haemorrhoids aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evista:

Evista (25,891 reports)

Haemorrhoids aggravated treatments and more:

Haemorrhoids aggravated (28 reports)

How severe was Haemorrhoids aggravated and when was it recovered:

Haemorrhoids aggravated in Evista

Expand to all the drugs that have ingredients of raloxifene hydrochloride:

Haemorrhoids aggravated and drugs with ingredients of raloxifene hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemorrhoids aggravated:

Haemorrhoids aggravated (1,316 drugs)

Browse all the conditions that are associated with Haemorrhoids aggravated:

Haemorrhoids aggravated (453 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raloxifene hydrochloride (the active ingredients of Evista) and Evista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.